P0435: Comparative analysis between capsule endoscopy and ileocolonoscopy for activity detection in ileal Crohn's disease. Preliminary results from the CAPITER study, a multicenter study from the Young Group of GETECCU.ECCO'25Year: 2025
Authors: Marquès-Camí, M.(1)*;Vergés, L.(1);Caballero-Mateos, A.M.(2);Carvaca, C.(3);Suárez-Ferrer, C.(4);Carballo-Folgoso, L.(5);Carballal, A.(6);Roig, C.(7);Fernández-Clotet, A.(8);Moreno, V.(9);Tejido, C.(10);Brunet-Mas, E.(11);Torres, G.(12);Huguet, J.M.(13);San-Román, C.(14);Benítez, J.M.(15);Zabana, Y.(16);
(1)Hospital Universitari Arnau de Vilanova and Institut de Recerca Biomèdica de Lleida IRBLleida, Gastroenterology, Lleida, Spain;(2)Hospital Santa Ana, Gastroenterology, Motril, Spain;(3)Hospital Gómez Ulla, Gastroenterology, Madrid, Spain;(4)Hospital Universitario La Paz, Gastroenterology, Madrid, Spain;(5)Hospital Universitario Central de Asturias, Gastroenterology, Oviedo, Spain;(6)Hospital Universitario de Cabueñes, Gastroenterology, Gijón, Spain;(7)Hospital de la Santa Creu i Sant Pau, Gastroenterology, Barcelona, Spain;(8)Hospital Clinic, Gastroenterology, Barcelona, Spain;(9)Hospital General Universitario Dr Balmis, Gastroenterology, Alicante, Spain;(10)Complejo Hospitalario Universitario de Ourense, Gastroenterology, Ourense, Spain;(11)Hospital Parc Taulí and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology, Sabadell, Spain;(12)Hospital General de Granollers, Gastroenterology, Granollers, Spain;(13)Hospital General Universitario de Valencia, Gastroenterology, Valencia, Spain;(14)Hospital Universitario de Toledo, Gastroenterology, Toledo, Spain;(15)Hospital Universitario Reina Sofía, Gastroenterology, Córdoba, Spain;(16)Hospital Universitari Mútua de Terrassa and Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology, Terrassa, Spain; On behalf of the Young Group of GETECCU
P0437: Positive anti-Saccharomyces cerevisiae antibodies do not affect clinical outcomes in pediatric patients with Crohn's disease treated with anti-TNF therapyECCO'25Year: 2025
Authors: LIng, D.(1);Grabovski, R.(1);Matar, M.(2);Shamir, R.(2);Shouval , D.S.(2);Weintraub, Y.(2)*;
(1)Tel Aviv University, Faculty of Medicine, Tel Aviv, Israel;(2)Schneider Children's Medical Center, Institute of Gastroenterology- Nutrition and Liver Diseases, Petach Tikva, Israel;
P0438: Altered Visceral Sensitivity in patients with Ulcerative Colitis in remission.ECCO'25Year: 2025
Authors: Trikola, A.(1)*;Mylonas, I.(1);Gerasimos , S.(2);Viazis, N.(1);
(1)Evangelismos General Hospital, Gastroenterology Department, Athens, Greece;(2)Athens Naval Hospital, Gastroenterology Department, Athens, Greece;
P0439: Ultrasound transmural healing reduces the risk of relapse in Crohn’s disease patients with endoscopic mucosal healing: results of a prospective studyECCO'25Year: 2025
Authors: Yzet, C.(1)*;Brazier, F.(1);Derval, E.(1);Pricope, D.(2);Vaneslander, P.(3);Dejour, V.(3);Diouf, M.(4);Ollier, A.(4);Fumery, M.(1);
(1)Amiens university hospital, Gastroenterology, Amiens, France;(2)Compiegne Hospital, Gastroenterology, Compiègne, France;(3)Clinique Saint Claude, Gastroenterology, Saint Quentin, France;(4)Amiens university hospital, biostatistic, Amiens, France;
P0440: Faecal and plasma zinc as predictors of relapse in quiescent Crohn’s Disease in the Stratifying Crohn’s Using Biomarker Assessment (SCUBA) studyECCO'25Year: 2025
Authors: Palmer, J.(1)*;Catchpole, A.(2);Talwar, D.(2);Veryan, J.(3);Colbert, R.(1);Seenan, J.P.(4);Macdonald, J.(4);Gerasimidis , K.(5);Gaya, D.R.(1);
(1)Glasgow Royal Infirmary, Gastroenterology, Glasgow, United Kingdom;(2)Glasgow Royal Infirmary, Biochemistry, Glasgow, United Kingdom;(3)University Hospital Monklands, Gastroenterology, Glasgow, United Kingdom;(4)Queen Elizabeth University Hospital, Gastroenterology, Glasgow, United Kingdom;(5)University of Glasgow, Clinical Nutrition, Glasgow, United Kingdom;
1 Siva S, Rubin DT, Gulotta G, Wroblewski K, Pekow J. Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases. 2017 Jan;23(1)doi:10.1097/MIB.0000000000000989
2 MJ M, S D, C T, et al. A prospective analysis of micronutrient status in quiescent inflammatory bowel disease - PubMed. Clinical nutrition (Edinburgh, Scotland). 2021 Jan;40(1)doi:10.1016/j.clnu.2020.05.010
P0441: Vitamin D seasonal fluctuation is more prominent in inflammatory bowel disease patients undergoing advanced therapiesECCO'25Year: 2025
Authors: Baz-Lopez, A.(1)*;Baston-Rey, I.(2);Marti-Marques , E.(1);Calviño-Suarez, C.(2);Santos-Blanco, E.(1);Ferreiro-Iglesias, R.(2);Blanco-Hortas, A.(3);Lopez-Roses, L.(1);Dominguez-Muñoz, J.E.(2);Barreiro-de Acosta, M.(2);
(1)Hospital Universitario Lucus Augusti, Gastroenterology Department, Lugo, Spain;(2)University Hospital Santiago De Compostela CHUS, Department of Gastroenterology- IBD Unit, Santiago De Compostela, Spain;(3)IDIS, Research Institute, Lugo, Spain;
P0442: Prevalence and Impact of E-cigarettes on Disease Outcomes in Patients with Inflammatory Bowel DiseaseECCO'25Year: 2025
Authors: Almuhaya, H.(1)*;Alashkar, R.(2);Alsebaai, D.(2);Albadawi , N.(1);Almutairdi, A.(1);Attamimi, M.(1);Desai, S.(3);Al-Bawardy, B.(1);
(1)King Faisal Specialist Hospital & Research Centre, Department of Internal Medicine- Division of Gastroenterology and Hepatology, Riyadh, Saudi Arabia;(2)Alfaisal University, Alfaisal University, Riyadh, Saudi Arabia;(3)King Faisal Specialist Hospital & Research Centre, Department of Biostatistics- Epidemiology and Scientific Computing, Riyadh, Saudi Arabia;
P0443: Prognosis of primary sclerosing cholangitis (PSC) in Hungary is independent of coexisting inflammatory bowel disease (IBD) and prognostic ability of the currently used PSC risk scores are limitedECCO'25Year: 2025
Authors: Vén, P.(1);Lénárt, Á.(2)*;Tornai, D.(3);Tóth, B.(3);Vitális, Z.(3);Tornai, I.(3);Tornai, T.(4);Altorjay , I.(3);Papp, M.(3);
(1)University of Pécs, Division of Gastroenterology- First Department of Medicine, Pécs, Hungary;(2)University of Debrecen, Gastroenterology, Debrecen, Hungary;(3)University of Debrecen, Division of Gastroenterology- Department of Internal Medicine- Faculty of Medicine, Debrecen, Hungary;(4)Semmelweis University, Institute of Pancreatic Diseases, Budapest, Hungary;
P0444: Frequency and Characteristics of Anorectal Pathologies in Patients with Inflammatory Bowel DiseaseECCO'25Year: 2025
Authors: Contreras Aviles, E.(1)*;Philippe Ponce, M.(1);Guinea Lagunes, A.(1);Almeida del Prado, G.(1);Sebastian Ocampo , V.(1); López Perez, R.(1);Jiménez Bobadilla, B.(2);De Leon Rendon, J.L.(3);
(1)Coloproctology Service of Hospital General de México ´´Dr. Eduardo Liceaga´´, Inflammatory Bowel Disease Clinic, Ciudad de México, Mexico;(2)Coloproctology Service of Hospital General de México ´´Dr. Eduardo Liceaga´´, Coloproctology Service, Ciudad de México, Mexico;(3)Coloproctology Service of Hospital General de Méxco ´´Dr. Eduardo Liceaga´´, Clínica de Enfermedad Inflamatoria Intestinal, Mexico, Mexico;
Misselwitz B, Rickenbacher A, Brand S. Klinik, Diagnostik und Therapie proktologischer Beschwerden bei Patienten mit chronisch entzündlichen Darmerkrankungen. Therapeutische Umschau. Revue therapeutique. 2021;78(9):547-558. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1024/0040-5930/a001309 Truong A, Zaghiyan K, Fleshner P. Anorectal Crohn’s Disease. Surg Clin North Am. 2019;99(6):1151-1162. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1016/j.suc.2019.08.012 D'Ugo S, Stasi E, Gaspari AL, Sileri P. Hemorrhoids and anal fissures in inflammatory bowel disease. Minerva Gastroenterol Dietol. 2015;61(4):223-233. Hamzaoglu I, Hodin RA. Perianal problems in patients with ulcerative colitis. Inflamm Bowel Dis. 2005;11(9):856-859. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1097/01.mib.0000174373.75977.b9 Xu S, Zhang L, Li Z, et al. Enhancing surgical precision: unveiling the impact of preoperative colonoscopy in anal fistula patients. BMC Gastroenterol. 2023;23:442. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1186/s12876-023-03066-x Yamamoto T, Allan RN, Keighley MR. Effect of fecal diversion alone on perianal Crohn's disease. World J Surg. 2000;24(10):1258-1263. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1007/s002680010250 Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004;350(9):876-885. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1056/NEJMoa030815 Márquez Velásquez JR, González Awique PS, Miranda Ruíz CA, Muñoz Zuluaga M, Miranda Ruíz LF. Uso de la anoscopia de alta resolución para la detección de displasia anal por papilomavirus en pacientes con enfermedad inflamatoria intestinal. Rev Colomb Gastroenterol. 2023;38(4):419-2. [citado 2024 Aug 29]. Disponible en: https://revistagastrocol.com/index.php/rcg/article/view/1048 El-Gazzaz G, Hull T, Church JM. Biological immunomodulators improve the healing rate in surgically treated perianal Crohn's fistulas. Colorectal Dis. 2012;14(10):1217-1223. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1111/j.1463-1318.2012.02944.x Gold SL, Cohen-Mekelburg S, Schneider Y, Steinlauf A. Perianal fistulas in patients with Crohn's disease, part 1: current medical management. Gastroenterol Hepatol (N Y). 2018;14(8):470-481. Smith RK, Paulson EC. Perianal fistulas in patients with inflammatory bowel disease. Semin Colon Rectal Surg. 2014;25(4):216-220.
P0445: High risk of colorectal cancer after high-grade dysplasia in Inflammatory Bowel Disease patientsECCO'25Year: 2025
Authors: DerksEduarda Wilhelmina, M.(1)*;te Groen, M.(1);Derikx, L.(2);Nagtegaal, I.(3);Hoentjen, F.(4);
(1)Radboud University Medical Center, Department of Gastroenterology, Nijmegen, The Netherlands;(2)Erasmus Medical Center, Department of Gastroenterology, Rotterdam, The Netherlands;(3)Radboud University Medical Center, Department of Pathology, Nijmegen, The Netherlands;(4)University of Alberta, Division of Gastroenterology- Department of Medicine, Edmonton, Canada;
1. Choi CH, Rutter MD, Askari A, et al. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview. Am J Gastroenterol. Jul 2015;110(7):1022-34. doi:10.1038/ajg.2015.65
2. Mooiweer E, van der Meulen-de Jong AE, Ponsioen CY, et al. Incidence of Interval Colorectal Cancer Among Inflammatory Bowel Disease Patients Undergoing Regular Colonoscopic Surveillance. Clin Gastroenterol Hepatol. Sep 2015;13(9):1656-61. doi:10.1016/j.cgh.2015.04.183
3. Shah SC, Ten Hove JR, Castaneda D, et al. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. Jul 2018;16(7):1106-1113 e3. doi:10.1016/j.cgh.2018.01.023
4. Singh K, Al Khoury A, Kurti Z, et al. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance. J Crohns Colitis. Sep 27 2019;13(10):1343-1350. doi:10.1093/ecco-jcc/jjz066
P0446: Increased risk of venous thromboembolism post hospital discharge in patients with Inflammatory Bowel Disease: a systematic review and meta-analysisECCO'25Year: 2025
Authors: Subhaharan, D.(1)*;Zaka, A.(2);Mridha, N.(3);Haig, A.(1);Mohsen, W.(1);Kakkadasam Ramaswamy, P.(1);
(1)Gold Coast University Hospital, Department of Digestive Health, Gold Coast, Australia;(2)Gold Coast University Hospital, Department of Cardiology, Gold Coast, Australia;(3)Prince Charles Hospital, Department of Cardiology, Brisbane, Australia;
P0448: Unravelling genetic versus environmental factors determining disease course in Inflammatory Bowel Disease: a population-based cohort study in first- and second-generation immigrantsECCO'25Year: 2025
Authors: D'hooghe, A.T.(1,2,3)*;Poulsen, G.J.(3);Sørensen, C.N.(3);Tandon, P.(4);Andersen, N.N.(3,5);Vermeire, S.(1,2);Verstockt, B.(1,2);Jess, T.(3,6);
(1)KU Leuven, Translational Research in Gastrointestinal Disorders- Department of Chronic Diseases and Metabolism CHROMETA, Leuven, Belgium;(2)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(3)Aalborg University- Center for Molecular Prediction of Inflammatory Bowel Disease PREDICT, Department of Clinical Medicine, Copenhagen, Denmark;(4)University of Toronto, Division of Gastroenterology and Hepatology- University Health Network, Toronto, Canada;(5)Zealand University Hospital, Department of Gastroenterology, Køge, Denmark;(6)Aalborg University Hospital, Department of Gastroenterology and Hepatology, Aalborg, Denmark;
1. Agrawal M, Corn G, Shrestha S, et al. Inflammatory bowel diseases among first-generation and second-generation immigrants in Denmark: a population-based cohort study. Gut. 2021;70(6):1037-43. doi: 10.1136/gutjnl-2020-321798.
P0449: qFIT as a predictor of relapse in quiescent Crohn’s disease – initial results from the Stratifying Crohn’s Using Biomarker Assessment (SCUBA) studyECCO'25Year: 2025
Authors: Palmer, J.(1)*;Catchpole, A.(2);Talwar, D.(2);Veryan, J.(3);Colbert, R.(1);Seenan, J.P.(4);Macdonald, J.(4);Gerasimidis , K.(5);Gaya, D.R.(1);
(1)Glasgow Royal Infirmary, Gastroenterology, Glasgow, United Kingdom;(2)Glasgow Royal Infirmary, Biochemistry, Glasgow, United Kingdom;(3)University Hospital Monklands, Gastroenterology, Glasgow, United Kingdom;(4)Queen Elizabeth University Hospital, Gastroenterology, Glasgow, United Kingdom;(5)University of Glasgow, Clinical Nutrition, Glasgow, United Kingdom;
1. S H, J K, A N, et al. Consecutive Measurements by Faecal Immunochemical Test in Quiescent Ulcerative Colitis Patients Can Detect Clinical Relapse - PubMed. Journal of Crohn's & colitis. 2016 Jun;10(6)doi:10.1093/ecco-jcc/jjw025
P0450: World-wide Development and Validation of the IBD LIFE Questionnaire and Country-specific Patterns of Normal Life ImpairmentECCO'25Year: 2025
Authors: Van Oostrom, J.(1)*;Anjie, S.(1);Lasa, J.(2);Karimi, N.(3);Horrigan, J.(4);Sareen, H.(5);Adi, B.(6);Ganesh, G.(6);Parks, M.L.(7);Broër, C.(8);de Kruif, A.(9);Peyrin-Biroulet, L.(10);Ye, B.D.(11);Banerjee, R.(6);Olivera, P.(12);Siegel, C.(4);Connor, S.(5);Gecse, K.(1);D'Haens, G.(1);
(1)Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Centro de Educación Médica e Investigación Clínica CEMIC, IBD Unit- Gastroenterology Section- Department of Internal Medicine, Buenos Aires, Argentina;(3)Australian National University- Canberra- Australia, Institute for Communication in Health Care, Sydney, Australia;(4)Dartmouth Hitchcock Medical Center, Department of Gastroenterology and Hepatology, Lebanon- New Hampshire, United States;(5)Liverpool Hospital- South West Sydney Clinical Campuses- UNSW Medicine and Health- UNSW Sydney- Sydney- Australia, Department of Gastroenterology, Sydney, Australia;(6)Asian institute of Gastroenterology, Department of gastroenterology and hepatology, Hyderabad, India;(7)Hospital Británico, Gastroenterology Department, Buenos Aires, Argentina;(8)University of Amsterdam, Faculty of Sociology, Amsterdam, The Netherlands;(9)Free University, Faculty of Science- Methodology and Applied Biostatistics, Amsterdam, The Netherlands;(10)University of Lorraine- CHRU-Nancy, Department of Gastroenterology, Nancy, France;(11)Asan Medical Center- University of Ulsan College of Medicine, Department of gastroenterology and hepatology, Seoul, Korea- Republic Of;(12)Lunenfeld-Tanenbaum Research Institute- Sinai Health System, Zane Cohen Centre for Digestive Diseases, Toronto- ON, Canada; IBD LIFE consortium
P0451: Using a machine learning model to assess agreement between inflammation in the rectosigmoid and entire colon in patients with ulcerative colitisECCO'25Year: 2025
Authors: George, A.(1);Gottlieb, K.(2);Baxi, S.(3);Eastman, W.(2);Colucci, D.(3);Battioui, C.(2);Wang, Y.(3);Lehrer, J.(4);Brodskiy, P.(4);Haft-Javaherian, M.(4);Rubin, D.T.(1)*;
(1)The University of Chicago Medicine Inflammatory Bowel Disease Center, Section of Gastroenterology- Hepatology- and Nutrition, Chicago, United States;(2)Eli Lilly & Company, Clinical Research, Indianapolis, United States;(3)Iterative Health Inc., Data & Insights, Cambridge, United States;(4)Iterative Health Inc., Machine Learning, Cambridge, United States;
Feagan, B. G., Khanna, R., Sandborn, W. J., Vermeire, S., Reinisch, W., Su, C., . . . & Sands, B. E. (2021). Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: Results from the tofacitinib OCTAVE trials. Alimentary Pharmacology & Therapeutics, 54(11-12), 1442-1453.
Hashash, J. G., Yu Ci Ng, F., Farraye, F. A., Wang, Y., Colucci, D. R., Baxi, S., . . . & Melmed, G. Y. (2024). Inter-and intraobserver variability on endoscopic scoring systems in crohn’s disease and ulcerative colitis: A systematic review and meta-analysis. Inflammatory Bowel Diseases, izae051.
Food and Drug Administration. Ulcerative Colitis: Developing Drugs for Treatment [Internet]. 2022 [cited 2024 Oct 17]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/ulcerative-colitis-developing-drugs-treatment
Rubin, D. T., Gottlieb, K., Colombel, J. F., Schott, J. P., Erisson, L., Prucka, B., . . . & McGill, J. (2023). Development of a novel ulcerative colitis Endoscopic Mayo Score prediction model using machine learning. Gastro Hep Advances, 2(7), 935-942.
P0452: Complicated and Extra-Complicated Crohn's Disease Course: a Prospective Inception Real-World CohortECCO'25Year: 2025
Authors: Sharar Fischler, T.(1,2)*;Goren, I.(1,3);Ollech, J.E.(1,2);Banai-Eran, H.(1,2);Avni-Biron, I.(1,2);Snir, Y.(1,2);Broitman, Y.(1,2);Freidenberg, A.(1,2);Pauker, M.H.(1,2);Dotan, I.(1,2);Yanai, H.(1,2);
(1)Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel;(2)Tel Aviv University, Faculty of Medical and Health Sciences, Tel Aviv, Israel;(3)SUNY Upstate Medical University, Division of Gastroenterology, Syracuse- New York, United States;
P0453: Intestinal Ultrasound Correlates with Patient-Reported IBD Disability in Ulcerative Colitis: A Step Towards Integrated MonitoringECCO'25Year: 2025
Authors: Eggermont, E.(1,2)*;Lenfant, M.(1,2);Fierens, L.(2);Vermeire, S.(1,2);Ferrante, M.(1,2);Sabino, J.(1,2);Verstockt, B.(1,2);
(1)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(2)Translational Research in Gastrointestinal Disorders, Department of Chronic Diseases and Metabolism CHROMETA- KU Leuven, Leuven, Belgium;
1. Allocca M et al. J Crohns Colitis 2023.
P0454: Predictive value of postoperative CRP levels on endoscopic recurrence in Crohn’s disease patients undergoing Ileocolic resectionECCO'25Year: 2025
Authors: Haanappel, A.(1)*;Van Tieghem, C.(2);Ali, M.(1);Wolthuis, A.(2);Vlug, M.(1);Bemelman, W.(1);D'Hoore, A.(2);Buskens, C.(1);Bislenghi, G.(2);
(1)Amsterdam UMC, Surgery, Amsterdam, The Netherlands;(2)University Hospitals Leuven, Abdominal Surgery, Leuven, Belgium;
- de Buck van Overstraeten A, Van Hoef S, Vermeire S, Ferrante M, Fieuws S, Wolthuis A, et al. Postoperative Inflammatory Response in Crohn's Patients: A Comparative Study. J Crohns Colitis. 2015;9(12):1127-31.
2. Iaculli E, Agostini M, Biancone L, Fiorani C, Di Vizia A, Montagnese F, et al. C-reactive protein levels in the perioperative period as a predictive marker of endoscopic recurrence after ileo-colonic resection for Crohn's disease. Cell Death Discov. 2016;2:16032.
3. Gionchetti P, Dignass A, Danese S, Magro Dias FJ, Rogler G, Lakatos PL, et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations. J Crohns Colitis. 2017;11(2):135-49.
